মো: ফজলুল হক
সিনিয়র শিক্ষক
১৫ জানুয়ারি, ২০২২ ০৮:৩৬ অপরাহ্ণ
'AstraZeneca booster generates higher antibodies against Omicron' , Observer Online Desk
AstraZeneca said on Thursday (Jan 13) that preliminary data from a trial
showed that its Covid-19 shot, Vaxzevria, generated an increase in antibodies
against the Omicron and other variants when given as a third booster dose,
reports Reuters.
The increased response, also against the Delta variant, was seen in a blood
analysis of people who were previously vaccinated with either Vaxzevria or an
mRNA vaccine, the drugmaker said, adding that it would submit this data to
regulators worldwide given the urgent need for boosters.
AstraZeneca has developed the vaccine with researchers from the University of
Oxford, and lab studies conducted by the university last month already found a
three-dose course of Vaxzevria boosted antibody levels in the blood against the
rapidly spreading Omicron variant.